Maria Chiara Finazzi

A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms

Alessandro Rambaldi, Chiara Maria Dellacasa, Guido Finazzi et al. · British Journal of Haematology · 2010 · 240 citations · Full text

Immunology, Pathology, Pharmacotherapy +20

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Abdulraheem Yacoub, John Mascarenhas, Heidi Kosiorek et al. · Blood · 2019 · 165 citations · Full text

Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts

Ayalew Tefferi, Mythri Mudireddy, Francesco Mannelli et al. · Leukemia · 2018 · 138 citations · Full text

A phase II study of <scp>G</scp>ivinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy

Guido Finazzi, Alessandro M. Vannucchi, Vincenzo Martinelli et al. · British Journal of Haematology · 2013 · 127 citations · Full text

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial

Tiziano Barbui, Alessandro M. Vannucchi, Valerio De Stefano et al. · The Lancet Haematology · 2021 · 125 citations · Full text

Polycythaemia Vera, Hematology, Low-pv Study +2